Schepers 1981.
Methods | Design: randomised double‐blinded (abstract only) No. eligible: not stated No. randomised: 107 No. analysed: 103 Drop‐outs/withdrawals: 4 (reasons not reported) Years of recruitment: not stated Setting: The Netherlands |
|
Participants | Inclusion criteria: premenopausal women undergoing abdominal hysterectomy Exclusion criteria: not stated Age: not stated Type of hysterectomy: abdominal | |
Interventions | Treatment: deposition (second‐generation cephalosporin) Control: placebo Route: IV Single/multiple doses: multiple Timing of doses: first dose 30 minutes preoperatively, second dose 6 hours later |
|
Outcomes | Postoperative infection Adverse effects (narrative data only) Follow‐up: not stated |
|
Funding | Not stated | |
Notes | No extractable data ‐ no denominators | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Described as randomised; no additional details |
Allocation concealment (selection bias) | Unclear risk | Method not described |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | States "double‐blind"; no additional details |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Proportions of withdrawals and reasons for withdrawal/drop‐out not reported |
Selective reporting (reporting bias) | High risk | Data not available on all prespecified outcomes; thus evidence of selective reporting |
Other bias | Unclear risk | Insufficient detail to determine risk |